Expression of CD44 and MDM2 in cholangiocarcinoma is correlated with poor clinicopathologic characteristics.
Year: 2019
Type: article
Study design: Observational Study
Abstract: =0.041) in patients with cholangiocarcinoma. CD44 and MDM2 significantly indicate poor clinicopathologic outcomes in patients with cholangiocarcinoma.
Source: Europe PMC (PubMed Central)
Institution: Suranaree University of Technology
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3006420025
